Cargando…
Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate
BACKGROUND: Submucous cleft palate (SMCP) requires surgical repair if symptomatic. The Furlow double-opposing Z-plasty is the preferred method in Helsinki cleft center. AIMS: To assess the efficacy and complications of Furlow Z-plasty in the treatment of symptomatic SMCP. METHODS: This retrospective...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521778/ https://www.ncbi.nlm.nih.gov/pubmed/37221637 http://dx.doi.org/10.1097/SCS.0000000000009385 |
_version_ | 1785110210175565824 |
---|---|
author | Pitkänen, Veera Szwedyc, Anika Alaluusua, Suvi Geneid, Ahmed Vuola, Pia Saarikko, Anne |
author_facet | Pitkänen, Veera Szwedyc, Anika Alaluusua, Suvi Geneid, Ahmed Vuola, Pia Saarikko, Anne |
author_sort | Pitkänen, Veera |
collection | PubMed |
description | BACKGROUND: Submucous cleft palate (SMCP) requires surgical repair if symptomatic. The Furlow double-opposing Z-plasty is the preferred method in Helsinki cleft center. AIMS: To assess the efficacy and complications of Furlow Z-plasty in the treatment of symptomatic SMCP. METHODS: This retrospective study reviewed documentation of 40 consecutive patients with symptomatic SMCP who underwent primary Furlow Z-plasty by 2 high-volume cleft surgeons at a single center between 2008 and 2017. Patients underwent perceptual and instrumental evaluation of velopharyngeal function (VPF) by speech pathologists preoperatively and postoperatively. RESULTS: The median age at Furlow Z-plasty was 4.8 years (SD 2.6, range 3.1–13.6). The overall success rate, including postoperative competent or borderline competent VPF, was 83%, and 10% required secondary surgery for residual velopharyngeal insufficiency. The success rate was 85% in nonsyndromic, and 67% in syndromic patients with no significant difference (P=0.279). Complications arose in only 2 (5%) patients. No children were found to have obstructive sleep apnea postoperatively. CONCLUSION: Furlow primary Z-plasty is a safe and effective operation for symptomatic SMCP with a success rate of 83% with only 5% rate of complications. |
format | Online Article Text |
id | pubmed-10521778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-105217782023-09-27 Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate Pitkänen, Veera Szwedyc, Anika Alaluusua, Suvi Geneid, Ahmed Vuola, Pia Saarikko, Anne J Craniofac Surg Clinical Studies BACKGROUND: Submucous cleft palate (SMCP) requires surgical repair if symptomatic. The Furlow double-opposing Z-plasty is the preferred method in Helsinki cleft center. AIMS: To assess the efficacy and complications of Furlow Z-plasty in the treatment of symptomatic SMCP. METHODS: This retrospective study reviewed documentation of 40 consecutive patients with symptomatic SMCP who underwent primary Furlow Z-plasty by 2 high-volume cleft surgeons at a single center between 2008 and 2017. Patients underwent perceptual and instrumental evaluation of velopharyngeal function (VPF) by speech pathologists preoperatively and postoperatively. RESULTS: The median age at Furlow Z-plasty was 4.8 years (SD 2.6, range 3.1–13.6). The overall success rate, including postoperative competent or borderline competent VPF, was 83%, and 10% required secondary surgery for residual velopharyngeal insufficiency. The success rate was 85% in nonsyndromic, and 67% in syndromic patients with no significant difference (P=0.279). Complications arose in only 2 (5%) patients. No children were found to have obstructive sleep apnea postoperatively. CONCLUSION: Furlow primary Z-plasty is a safe and effective operation for symptomatic SMCP with a success rate of 83% with only 5% rate of complications. Lippincott Williams & Wilkins 2023-10 2023-05-24 /pmc/articles/PMC10521778/ /pubmed/37221637 http://dx.doi.org/10.1097/SCS.0000000000009385 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Mutaz B. Habal, MD. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Clinical Studies Pitkänen, Veera Szwedyc, Anika Alaluusua, Suvi Geneid, Ahmed Vuola, Pia Saarikko, Anne Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate |
title | Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate |
title_full | Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate |
title_fullStr | Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate |
title_full_unstemmed | Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate |
title_short | Outcomes of Primary Furlow Double-Opposing Z-plasty for the Treatment of Symptomatic Submucous Cleft Palate |
title_sort | outcomes of primary furlow double-opposing z-plasty for the treatment of symptomatic submucous cleft palate |
topic | Clinical Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521778/ https://www.ncbi.nlm.nih.gov/pubmed/37221637 http://dx.doi.org/10.1097/SCS.0000000000009385 |
work_keys_str_mv | AT pitkanenveera outcomesofprimaryfurlowdoubleopposingzplastyforthetreatmentofsymptomaticsubmucouscleftpalate AT szwedycanika outcomesofprimaryfurlowdoubleopposingzplastyforthetreatmentofsymptomaticsubmucouscleftpalate AT alaluusuasuvi outcomesofprimaryfurlowdoubleopposingzplastyforthetreatmentofsymptomaticsubmucouscleftpalate AT geneidahmed outcomesofprimaryfurlowdoubleopposingzplastyforthetreatmentofsymptomaticsubmucouscleftpalate AT vuolapia outcomesofprimaryfurlowdoubleopposingzplastyforthetreatmentofsymptomaticsubmucouscleftpalate AT saarikkoanne outcomesofprimaryfurlowdoubleopposingzplastyforthetreatmentofsymptomaticsubmucouscleftpalate |